Kim and colleagues demonstrated that NDRG2 expression significantly suppressed tumor invasion by inhibiting MMP activities, an angiogenic switch during carcinogenesis, which is regulated through the NF-κB signaling pathway in melanoma (213). Here, NDRG2 is linked to melanoma.